Kolexia
Deschenes Georges Pédiatrie
Deschenes Georges
Pédiatrie
Hôpital Robert-Debré
Paris, France
226 Activités
4 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome néphrotique Maladies du rein Protéinurie Défaillance rénale chronique Cystinose Hyperoxalurie primaire Syndrome de Bartter Insuffisance rénale chronique Hyperoxalurie

Collaborateurs

Voir plus
Hogan Julien
Hogan Julien
Hôpital Robert-Debré, Paris, France
Baudouin Veronique
Baudouin Veronique
Hôpital Robert-Debré, Paris, France
Kwon Theresa
Kwon Theresa
Hôpital Robert-Debré, Paris, France
Dossier Claire
Dossier Claire
Hôpital Robert-Debré, Paris, France

Industries

Voir plus
Biocodex
4 collaboration(s)
Dernière en 2020
Alnylam
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
MAJESTY: A Phase III Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients With Primary Membranous Nephropathy
Essai Clinique (Roche)   21 mars 2024
POSTERITY: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescent Patients With Active Class III or IV Lupus Nephritis, Including an Evaluation of Open Label Safety and PK in a Cohort of Pediatric Patients (Aged 5 to < 12)
Essai Clinique (Roche)   15 mars 2024
INShore: A Phase III, International, Multicenter, Randomised Open Label Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Patients With Childhood Onset Idiopathic Nephrotic Syndrome
Essai Clinique (Roche)   27 février 2024
CYSTEA-BONE: A European, Multicenter, Prospective Clinical Study to Evaluate Cysteamine Toxicity on Human Osteoclasts. The CYSTEA-BONE Clinical Study.
Essai Clinique (Hospices Civils de Lyon)   27 février 2024
ILLUMINATE-A: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study With an Extended Dosing Period to Evaluate the Efficacy and Safety of Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1
Essai Clinique (Alnylam)   13 février 2024
OBIRINS: Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome : a Double-blind Multicenter Randomized Controlled Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   08 novembre 2023
Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children.
Clinical journal of the American Society of Nephrology : CJASN   06 septembre 2023
Antenatal: Multicentre Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves
Essai Clinique (CHU Toulouse)   22 août 2023
Obinutuzumab in Primary FSGS: A Single-center, Phase 2 Open-label Trial Evaluating the Efficacy and Safety of OBINUTUZUMAB in Treatment of Immunosuppression-dependent or Immunosuppression/Treatment-resistant Primary FSGS, or Contraindication/Patient Refusal to Take High Dose Corticosteroids
Essai Clinique (Genentech)   13 juin 2023
FC038: Efficacy of Levamisole for Maintaining Remission after the First Flare of Steroid Sensitive Nephrotic Syndrome in Children: The Nephrovir-3 Randomized Controlled Trial
59th ERA Congress, 19-22 May 2022: Congress Abstracts   03 mai 2022